To stimulate innovation and entrepreneurship in both education and research IXA has, in collaboration with the City of Amsterdam, developed the valorisation program IXAnext; Talent for Innovation. All Amsterdam universities and knowledge institutes are involved: HvA, UvA, VU, Amsterdam UMC and the NWO institutes AMOLF and NIKHEF. In a five year periode, 2017-2021, they collaborate in utilizing and disseminate knowledge and stimulate economic activity and entrepreneurship. All for the greater good and benefit of Amsterdams research and entrepreneurial ecosystem.
Benefits for researchers, teachers, students, entrepreneurs, companies… for who not?
The program offers facilities and funding, infrastructure, educational measures, a network and much more. Researchers, teachers and students have the incubators Amsterdam Venture Studios and Demonstrator Lab at their disposal to develop and test their business cases or accommodate their start-up activities.
Companies and non profits can benefit from the latest scientific expertise and research facilities with the Physics on Demand service. The Research Facilities database helps R&D departments to find specialized, high end equipment and instruments.
Teachers in Entrepreneurship can find inspiration for their education program and lessons with the Entrepreneurship cases and the pilot Blended Learning.
Students with plans for a start-up can profit from the knowledge of mentors found through the platform Startup and Running.
It is save to state IXAnext offers something for everyone.
MedTech startup Sirius Medical has received CE Mark approval for Sirius Pintuition, a non-radioactive device to localize breast tumors. In 2016 Bram Schermers, then a scientist at NKI, pitched an early concept at the annual Amsterdam Science & Innovation Awards and won first prize! His pitch also caught the attention of seasoned entrepreneur Hubert Martens, […]News
An annual survey held by the program directors of the Joint Master Entrepreneurship (UvA/ VU), Bram Kuijken and Enno Masurel, has found that 17.8% of alumni have founded their own company and 11.0% are currently working freelance. Additionally, the study found that 41.9% of alumni is employed by a startup (19.7%) or a scale-up (22.2%). […]News
CimCure, a spin-off of Amsterdam UMC and focusing on cancer immunotherapies for solid tumors, signed a strategic partnership agreement for in-licensing CimCure’s iBoost technology with Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and bacterial vaccines. The iBoost (immune boost) technology was developed at Amsterdam […]News